Position in EXEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,181,680
-$245,063 QoQ
Shares Held
260,706
0.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92.63538238475523.ToString("F0")%
Shared 0.ToString("F0")%
None 7.364617615244759.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLOBEFLEX CAPITAL L P holds $38,255,818 across 17 Biotechnology names. EXEL ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
260,706 | $11,181,680 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
450,580 | $11,156,360 | |
| 3 | RIGL |
Rigel Pharmaceuticals Inc
|
217,839 | $5,890,366 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
349,651 | $2,234,269 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,594 | $2,002,795 | |
| 6 | INCY |
Incyte Corp
|
15,643 | $1,472,319 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
214,350 | $846,682 | |
| 8 | BDTX |
Black Diamond Therapeutics, Inc.
|
305,276 | $650,237 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,181,680 | 260,706 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,426,743 | 260,706 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $10,767,157 | 260,706 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $41,193,465 | 934,516 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,221,221 | 926,902 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $32,472,528 | 975,151 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,328,678 | 320,951 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,891,179 | 217,676 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,999,341 | 210,676 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,054,117 | 210,676 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,886,949 | 223,659 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,168,851 | 113,493 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,113,613 | 108,893 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,746,643 | 108,893 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,021,355 | 128,913 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $644,087 | 30,936 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $701,319 | 30,936 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $565,510 | 30,936 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $924,452 | 43,730 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $796,760 | 43,730 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $987,860 | 43,730 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $1,015,775 | 41,545 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,265,009 | 53,286 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,179,225 | 68,480 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||